What is Meridian Bioscience?
Meridian Bioscience is a fully integrated life science company focused on the development, manufacturing, marketing, and distribution of a comprehensive array of innovative diagnostic and life science products. The company plays a crucial role in providing essential raw materials for immunological and molecular tests, catering to diverse applications across human, animal, plant, and environmental sectors. Its diagnostic solutions span molecular platforms, immunoassay systems, and blood chemistry tools, addressing critical disease areas such as gastrointestinal, respiratory, sexually transmitted, and tropical diseases. Serving a global clientele of healthcare providers, research centers, and biotech firms in over 70 countries, Meridian Bioscience, headquartered in Cincinnati, Ohio, is committed to delivering speed, accuracy, and simplicity in its offerings, thereby redefining possibilities from initial discovery through to final diagnosis.
How much funding has Meridian Bioscience raised?
Meridian Bioscience has raised a total of $525M across 2 funding rounds:
Other Financing Round
$25M
Debt
$500M
Other Financing Round (2022): $25M, investors not publicly disclosed
Debt (2023): $500M led by Export-Import Bank of Korea, J.P. Morgan Asset Management, PNC Financial Services Group Inc, Kookmin Bank, Citi, Standard Chartered, Industrial Bank of Korea, and Standard Chartered Bank Ghana
Key Investors in Meridian Bioscience
Export-Import Bank of Korea
The Export–Import Bank of Korea is the official export credit agency of South Korea, providing financial support for international trade and investment.
J.P. Morgan Asset Management
J.P. Morgan Asset Management is a global financial services firm specializing in investment management and wealth advisory services, offering a broad range of investment products and strategies.
PNC Financial Services Group Inc
The PNC Financial Services Group, Inc. is a diversified financial services company providing retail banking, corporate and institutional banking, and asset management services.
What's next for Meridian Bioscience?
The substantial enterprise-level funding secured by Meridian Bioscience positions the company for accelerated growth and enhanced market penetration. This capital infusion is expected to fuel further research and development initiatives, potentially expanding its diagnostic platforms and broadening its product applications. Strategic investments of this magnitude often signal an intent to scale operations, pursue key acquisitions, or strengthen global distribution networks. Meridian Bioscience is likely to leverage this financial backing to solidify its competitive advantage in the rapidly evolving life science and diagnostics landscape, driving innovation and expanding its reach to meet critical global health needs.
See full Meridian Bioscience company page
